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(57) ABSTRACT 
Metal nanoshells are fabricatedby admixing an aqueous solu-
tion of metal ions with an aqueous solution of apoferritin 
protein molecules, followed by admixing an aqueous solution 
containing an excess of an oxidizing agent for the metal ions. 
The apoferritin molecules serve as bio-templates for the for-
mation of metal nanoshells, which form on and are bonded to 
the inside walls of the hollow cores of the individual apofer-
ritin molecules. Control of the number of metal atoms which 
enter the hollow core of each individual apoferritin molecule 
provides a hollow metal nonparticle, or nanoshell, instead of 
a solid spherical metal nanoparticle. 
6 Claims, 5 Drawing Sheets 
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FABRICATION OF METAL NANOSHELLS 
CROSS-REFERENCE TO RELATED 
APPLICATION 
This application claims the benefit of U.S. Provisional 
Application No. 60/830,749, filed on Jul. 13, 2006 for "Fab-
rication of Metal Nanoshells Derived By A Biotemplate." 
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH OR DEVELOPMENT 
The U.S. Government has a paid-up license in this inven-
tion and the right in limited circumstances to require the 
patent owner to license others on reasonable terms, as pro-
vided for by the terms of Contract No. NCC-1-02043 
awarded by the National Aeronautics and Space Administra-
tion, and Science and Technology Corporation Contract No. 
L-71407D. 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
This invention relates generally to nanoscale particles. It 
relates particularly to a process for fabricating hollow metal 
nanostructures, or metal nanoshells, employing ferritin as a 
bio-template. 
2. Description of Related Art 
A great interest currently exists in the synthesis and char-
acterization of hollow metal nanostructures, because of their 
surface properties and catalytic activities, which are different 
from their solid counterparts. Most early work in this field 
involved hollow nanostructures of several hundreds of 
nanometers. Recently, the preparation of hollow nanostruc-
tures on the scale of tens of nanometers was demonstrated, 
employing a replacement reaction with a solid silver template 
and a nonoscale Kirkendall effect, respectively. However, 
such a fabrication process is very complicated, and requires 
the use of organic solvents. Moreover, it has been found 
generally difficult to form stable hollow metal nanoparticles, 
and even solid metal nanoparticles, because of strong mag-
netic interactions in magnetic particle systems. 
BRIEF SUMMARY OF THE INVENTION 
Accordingly, it is a primary object of the present invention 
to provide what is not available in the art, viz., an uncompli-
cated, yet highly efficacious process for the fabrication of 
hollow metal nanostructures, or metal nanoshells, which pro-
cess does not require the employment of organic solvents or 
other reagents which present handling difficulties. Moreover, 
it is another primary obj ect of the present invention to provide 
a process which produces hollow metal nanoparticles which 
are stable. 
These primary objects and their attending benefits are 
achieved by providing a process for the fabrication of metal 
nanoshells, which process includes employing apoferritin 
protein molecules in aqueous solution to act as biotemplates 
in the formation of hollow metal nanoparticles, and to func-
tion as separators between the hollow metal nanoparticles, 
once they have been formed. In the present process the empty 
cores of the apoferritin protein molecules are reconstituted 
with a metal, esp. a transition metal. Controlling the number 
of metal atoms introduced into each apoferritin molecule 
results in the formation of a metal nanoshell within each 
2 
apoferritin protein molecule, instead of the formation of a 
solid metal nanoparticle therein, which would otherwise 
result. 
Potential applications of the metal nanoshells include 
5 enhanced MRI diagnostic contrast agents, tumor hyperther- 
mia therapies, retinal detachment therapies, and magnetic 
field-guided drug delivery systems and radioactive therapies. 
BRIEF DESCRIPTION OF THE SEVERAL 
10 	 VIEWS OF THE DRAWINGS 
For a more complete understanding of the present inven-
tion, including its primary objects and attending benefits, 
reference should be made to the DETAILED DESCRIPTION 
15 OF THE INVENTION, which is set forth below. This 
Detailed Description should be read together with the accom-
panying Drawings, wherein: 
FIG. lA and FIG. 1B are drawings prepared from field 
emission-scanning electron microscopy (FE-SEM) images of 
20 apoferritin protein molecules (having 1000 cobalt atoms per 
apoferritin protein molecule core) immobilized on a holey 
carbon coated copper calibration grid; the scale bars are 40 
mu and 20 mu, respectively; 
FIG. 1C and FIG. 1D are drawings prepared from field 
25 emission-scanning electron microscopy equipped with trans-
mission electron microscopy (STEM) images of apoferritin 
protein molecules (having 1000 cobalt atoms per apoferritin 
protein molecule core) immobilized on a holey carbon coated 
copper calibration grid; the scale bars are 40 nm and 20 mu, 
30 respectively; 
FIG. 2A is a drawing prepared from a STEM image of 
apoferritin protein molecules (having 200 cobalt atoms per 
apoferritin protein molecule core), immobilized on a holey 
carbon coated copper calibration grid; the scale bar is 8 mu; 
35 FIG. 2B is a drawing prepared from a STEM image of 
apoferritin protein molecules (having 1000 cobalt atoms per 
apoferritin protein molecule core) immobilized on a holey 
carbon coated copper calibration grid; the scale bar is 5 mu; 
FIG. 2C is a drawing prepared from a STEM image of 
40 apoferritin protein molecules (having 2000 cobalt atoms per 
apoferritin protein molecule core) immobilized on a holey 
carbon coated copper calibration grid; the scale bar is 5 mu; 
FIG. 3A is a drawing prepared from a STEM image of 
apoferritin protein molecules (having 1000 cobalt atoms per 
45 apoferritin protein molecule core) immobilized on a holey 
carbon coated copper calibration grid; the scale bar is 5 mu; 
FIG. 3B is a drawing prepared from a STEM image of 
apoferritin protein molecules (having 2000 cobalt atoms per 
apoferritin protein molecule core) immobilized on a holey 
50 carbon coated copper calibration grid; the scale bar is 5 mu; 
FIG. 4 is a plot of absorbance vs. wavelength showing 
UV-Visible absorption spectra of apoferritin and various 
cobalt oxide-containing apoferritins; and 
FIG. 5 is a schematic depicting the growth mechanism for 
55 incremental numbers of cobalt oxide units introduced into the 
hollow core of an apoferritin protein molecule. 
DETAILED DESCRIPTION OF THE INVENTION 
60 	 To carry out the present process for the fabrication of 
metallic nanoshells, a first aqueous solution is provided. This 
first aqueous solution is a buffered solution of molecules of an 
apoferritin protein. Such apoferritin protein molecules are 
ferritin protein molecules whose inner metallic cores have 
65 been removed, e.g., in vitro by reduction and chelation, 
employing the molecular channels which run through each 
ferritin protein molecule from its outer periphery to its inner 
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core. A hollow inner core is thereby presented. A preferred 
apoferritin protein is an apo horse spleen ferritin protein 
(ApoHoSF). Very beneficial results are achieved if the first 
aqueous solution is a 1 mg per ml ApoHoSF solution which 
has been adjusted to pH 8.5 in 25 mM of MOPS buffer with 50 5 
mM NaCl. 
An evenly-distributed loading of metal ions among the 
apoferritin protein molecules of the first aqueous solution is 
then provided. This is accomplished by gradually admixing a 
second aqueous solution, which contains the metal ions, with 10 
the first aqueous solution, which contains the apoferritin pro-
tein molecules, to form a first admixture. It is preferred if the 
metal ions are transition metal ions, and morepreferable if the 
ions are of cobalt, iron, manganese, vanadium, nickel, zinc, 
copper, or silver. Very good results have been obtained if 15 
cobalt is employed in the present process. Especially benefi-
cial results have been obtained if the second aqueous solution 
is a 50 mM solution of cobalt sulfate. 
The loading or number of metal atoms per individual apo-
ferritin protein molecule in the first admixture is determined 20 
by calculation, employing the volume of the second aqueous 
solution employed along with the concentration of metal ions 
therein, as well as the volume of the first aqueous solution 
employed along with the concentration of apoferritin protein 
therein. The optimal loading is determined empirically, as 25 
discussed below. 
A third aqueous solution is then admixed with the first 
admixture. The third aqueous solution contains a calculated 
excess of oxidizing agent for the metal ions employed. Espe-
cially good results are obtained if the third aqueous solution is 30 
a 3 volume percent solution of hydrogen peroxide. 
The mechanism for the formation of metallic nanoshells is 
considered to be as follows: Metal ions enter into the hollow 
core of each of the apoferritin molecules through the molecu- 
lar channels therein. Chemical bonds are then formed 35 
between the metal ions and functional groups which are 
located on the wall of the hollow core of each apoferrition 
molecule during oxidation of the metal ions by the oxidizing 
agent. As discrete metallic nanoparticles are formed and then 
merged within the hollow core, a composite metallic 40 
nanoshell is formed on the wall of the hollow core where it is 
attached thereto, instead of a single, solid, composite metallic 
nanoparticle being formed within the core. 
The optimal number of metal atoms per individual apofer-
ritin protein molecule is empirically determined as that num- 45 
ber of metal atoms which is sufficient to provide a subatan-
tially integral, composite metallic nanoshell formed within, 
and attached to the wall of the hollow core, but which is 
insufficient to provide an integral, composite spherical metal- 
lic nanoparticle which, although formed within, and attached 50 
to the wall of the hollow core, has no empty space in the center 
thereof. 
Very beneficial results are obtained in the practice of the 
present invention if the number of metal atoms per individual 
apoferritin protein molecule is within the range of about 55 
1000-2000. 
EXAMPLES 
The following Examples are presented as being illustrative 60 
of the present invention, and are not intended to limit its 
scope. 
ApoHoSF solution (1 mg/m7) was adjusted to a pH 8.5 in 
25 mM MOPS buffer with 50 mM NaCl. COSO 4 (50 mM) was 
used as a cobalt source and gradually added to the ApoHoSF 65 
solution, followed by the addition of an excess amount of 
H2O2 (3 vol. %). The Cobalt was added very slowly and 
4 
gradually to achieve a certain loading of metal atoms evenly 
distributed into the ferritin. We reconstituted the ferritins 
having 200 Co (CO211) to 2000 Co (CO21,,)  atoms per ferritin 
in increments of 200 atoms. 
Field emission-scanning electron microscopy (FE-SEM), 
and FE-SEM equipped with a scanning transmission electron 
microscopy (STEM, Hitachi S-5200) were used for the char-
acterization of reconstituted Co-cored ferritins. Immobilized 
Co-cored ferritins on a holey carbon coated copper calibra-
tion grid were thoroughly rinsed with doubly distilled, deion-
ized water, dried in a vacuum atmosphere, and then subjected 
to microscopic analysis. FE-SEM and STEM were used to 
obtain the whole images at the same acceleration voltage of 
25 keV. FIGS. 1A, 113, 1C and 1D show FE-SEM and STEM 
images of reconstituted Co-cored ferritins on a copper cali-
bration grid. The STEM (FIGS. 1C and 1D) images show a 
clear view of solid cores without protein shell at a relatively 
low magnification. Ultraviolet-visible (UV-Vis) spectra were 
obtained from a Perkin-Elmer Lambda 900 light source. The 
ferritin protein in micro quartz cuvette was adjusted to the 
final concentration of 0.33 mg/ml diluted with 25 mM MOPS 
buffer at pH 8.5. The transmission spectra were measured 
from 900 nm to 200 nm at a scan speed of 150 nm/min. 
FIGS. 2A, 2B and 2C are scanning transmission electron 
microscopy (STEM, Hitachi S-5200) images of reconstituted 
Co-cored ferritins on a holey carbon coated calibration grid. 
When the ferritin contains 200 Co atoms in the ferritin inte-
rior, cobalt oxides were formed and evenly distributed on the 
ferritin interior wall (FIG. 2A). The size of cobalt oxides was 
2 mu. We can only see the metal cores in the ferritin through 
STEM imaging due to the relatively low density of the ferritin 
protein shell. Normally, eight hydrophilic channels along the 
four fold symmetric axis of the apoferritin protein shell are 
considered to be the pathways of metal ions into the ferritin 
interior. Once the metal ions enter the ferritin interior, they 
form chemical bonds during the oxidation process of the 
metal ions with the functional groups of the interior protein 
wall. It is very likely that the metal oxides are combined with 
carboxylate groups on the interior protein wall. The cobalt is 
thus attached to the inside wall of the hollow protein core. If 
there was not an interaction with the interior protein wall, a 
single nanoparticle would be formed within and not attached 
to the hollow core of an apoferritin in order to reduce surface 
tension. Once the seeds of metal oxides are formed, the nano-
particles inside the apoferritin grow auto-catalytically along 
the interior wall of the hollow core and then merge together 
during repetitions of Co(II) and H 2O2 additions. 
When the ferritin contains over 1000 Co atoms, the cobalt 
oxides form a hollow nanoparticle in the ferritin interior (FIG. 
213). STEM images show a clear circle with a hollow core 
through merging of the nanoparticles (FIG. 213). The size of 
hollow nanoparticlewas about 6 mu, which is smallerthanthe 
inner diameter of the hollow apoferritin core. FIGS. 3A and 
3B show STEM images of reconstituted Co-cored ferritins 
with different numbers of cobalt atoms. The wall thickness 
and size of hollow 002000  (FIG. 313) core are somewhat larger 
than Co....  core (FIG. 3A). 
Mineralized ferritin solution with Co(II) and H 2O2 showed 
a homogeneous olive-green color from the specific oxidative 
mineralization process at pH 8.5. The UV-Visible absorption 
spectra showed well-defined peaks at 280 nm (protein) and 
225 mn with a shoulder at 350 mn (corresponding to cobalt 
oxides, especially cobalt oxyhydroxide (COOOH)). (See FIG. 
4). Addition of the Co(II) and H 2O2 to the ApoHoSF solution 
results in the convolution of the protein absorption band at 
280 nm with a new absorption band at 225 mu, having a 
shoulder at 350 mu. These two peaks related to the core 
US 8,217,143 B2 
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material shifted to the higher wavelengths as the number of 
metal atoms increased within the ferritin. 
The first step of metal nanoshell formation is a nucleation 
of small nanoparticles in the interior (hollow core) of the 
ferritin protein shell. Referring now to FIG. 5, it is considered 
that the metal ions entered through the hydrophilic channels 
in the ferritin and combined with the carboxylate groups of 
the ferritin interior wall, thus forming discrete nanoparticles 
during an oxidative reaction along the ferritin interior wall 
(Step 1). The discrete nanoparticles continue to grow along 
the ferritin interior wall (Step 2). In a merging step, a hollow 
nanoparticle forms through the merging of discrete nanopar-
ticles (Step 3). The size of a particular hollow nanoparticle is 
somewhat decreased because of the formation of metallic 
bonds. Finally, the hollow nanoparticle is grown with a 
thicker metal wall (Step 4). The nanoparticle formed has an 
empty core at this point. This is why one should not com-
pletely fill in the ferritin interior or hollow core with a theo-
retical number of Co atoms through the reconstitution proce-
dure. Employing this growth mechanism renders hollow 
metal nanoparticles or metal nanoshells easily by controlling 
the number of metal atoms entering the interior or hollow core 
of the apoferritin. 
We claim: 
1. A process for the fabrication of metallic nanoshells, 
which process comprises: 
(a) providing a first aqueous solution, which is a buffered 
solution of an apoferritin protein, wherein the apofer-
ritin protein is selected from the group consisting of 
horse spleen ferritin and bacterial ferritin, each of the 
individual molecules of said apoferritin protein having 
molecular channels running therethrough from the outer 
periphery thereof to an inner core thereof, the channels 
having enabled removal of substantially all inorganic 
material from the inner core thereof, 
(b) providing an evenly-distributed loading of metal ions, 
wherein the metal ions are selected from the group con-
sisting of transition metals and noble metals, among the 
apoferritin protein molecules of the first solution by 
forming a first admixture prepared by gradually admix-
ing a second aqueous solution containing the metal ions 
with the first aqueous solution, the volume of the second 
6 
aqueous solution employed, along with the concentra-
tion of metal ions in the second aqueous solution, being 
utilized along with the volume of the first aqueous solu-
tion employed and the concentration of apoferritin pro- 
s tein in the first aqueous solution, to calculate the number 
of metal atoms per individual apoferritin protein mol-
ecule in the first admixture, the optimum thereof being 
that number of metal atoms which is sufficient to provide 
a substantially integral, composite metallic nanoshell 
10 formed within, and attached to the wall of the hollow 
core, but which is insufficient to provide an integral, 
composite spherical metallic nanoparticle which, 
although formed within, and attached to the wall of the 
hollow core, has no empty space in the center thereof; 
15 (c) gradually admixing a third aqueous solution with the 
first admixture, the third aqueous solution containing a 
calculated excess of oxidizing agent for the metal ions 
employed; whereby metal ions enter into the hollow 
inner core of each of the apoferritin molecules through 
20 the molecular channels therein, chemical bonds being 
formed between the metal ions and functional groups 
located on the wall of the hollow core of each of the 
apoferritin molecules during oxidation of the metal ions 
by the oxidizing agent, so that as discrete metallic nano- 
25 particles are formed and merged within the hollow core, 
a composite metallic nanoshell is formed on the wall of 
the hollow core and attached thereto, instead of a single, 
solid, composite metallic nanoparticle being formed 
within the core. 
30 2. The process of claim 1, wherein the optimal number of 
metal atoms per individual apoferritin protein molecule is 
within the range of about 1000-2000. 
3. The process of claim 1, wherein the metal is a transition 
metal. 
35 	 4. The process of claim 3, wherein the metal is selected 
from the group consisting of cobalt, iron, manganese, vana-
dium, nickel, zinc, copper and silver. 
5. The process of claim 1, wherein the metal is cobalt. 
6. The process of claim 1, wherein the first aqueous solu-
40 tion is a 1 mg per ml ApoHoSF solution which has been 
adjusted to pH 8.5 in 25 mM MOPS buffer with 50 mM NaCl. 
